Dr. Edward Fry, new President of the American College of Cardiology, discusses the results of the POISE-3 trial, which investigated the efficacy and safety of tranexamic acid in patients undergoing noncardiac surgery.
Dr. Edward Fry, new President of the American College of Cardiology, discusses the results of the POISE-3 trial, which investigated the efficacy and safety of tranexamic acid in patients undergoing noncardiac surgery.